drugset / Trial / NCT02809378

The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV

NCT02809378

RandomizedParallel-groupDouble-blindPrevention

Summary

The incidence of postoperative nausea and vomiting (PONV) after thyroidectomy have been shown to be relatively high compared other surgeries, with a reported incidence 65-75 %. PONV may increase patient discomfort, delay patient discharge, and increase the cost of patient care, the risk of postoperative bleeding which may potentially cause airway obstruction. It is reported that the maintenance of anesthesia with propofol-remifentanil or sevoflurane-propofol-remifentanil decreased the incidence of PONV compared sevoflurane alone, but failed to demonstrate the decreased incidence of PONV in 6-24 hr postoperative period in patients undergoing thyroidectomy. Administration of Palonosetron, newly developed 5-HT3 antagonists with long half life (48 hrs) may decrease the incidence of PONV particularly during this period. The purpose of this study was to evaluate and compare the incidence of PONV after thyroidectomy with three different anesthetic methods, sevoflurane or sevoflurane-propofol-remifentanil or sevoflurane-propofol-remifentanil-palonosetron in woman patients.

Timeline

Start
2016-06
Primary completion
2017-04-20
Completion
2017-04-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Palonosetron Other / unclassified 75 ug Intravenous
Subject Propofol Small molecule Intravenous
Subject Remifentanil Small molecule
Subject Thiopental Small molecule 4 mg/kg Intravenous
Subject Thiopental Small molecule 5 mg/kg Intravenous
Background Sevoflurane Other / unclassified 1.6 % Inhaled
Background Sevoflurane Other / unclassified 2.5 % Inhaled

Indications

No indication recorded.